Our study was the first to systematically reveal the correlation between TRIB3 and clinical pathological grade of ccRCC and patient prognosis and to clarify the influence of promoting or inhibiting TRIB3 in terms of cell biological behaviors such as the invasiveness of ccRCC cells. Here, TRIB3 is linked to nonpapillary renal cell carcinoma.